Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 159

Similar articles for PubMed (Select 18063236)

1.

Plaque reduction neutralization test for measles antibodies: Description of a standardised laboratory method for use in immunogenicity studies of aerosol vaccination.

Cohen BJ, Audet S, Andrews N, Beeler J; WHO working group on measles plaque reduction neutralization test.

Vaccine. 2007 Dec 21;26(1):59-66. Epub 2007 Nov 12.

PMID:
18063236
2.

Comparison of plaque reduction neutralisation test (PRNT) and measles virus-specific IgG ELISA for assessing immunogenicity of measles vaccination.

Cohen BJ, Doblas D, Andrews N.

Vaccine. 2008 Nov 25;26(50):6392-7. doi: 10.1016/j.vaccine.2008.08.074. Epub 2008 Oct 1.

PMID:
18834911
3.

Aerosolized measles and measles-rubella vaccines induce better measles antibody booster responses than injected vaccines: randomized trials in Mexican schoolchildren.

Bennett JV, Fernandez de Castro J, Valdespino-Gomez JL, Garcia-Garcia Mde L, Islas-Romero R, Echaniz-Aviles G, Jimenez-Corona A, Sepulveda-Amor J.

Bull World Health Organ. 2002;80(10):806-12. Epub 2002 Nov 28.

4.

Immunogenicity of aerosol measles vaccine given as the primary measles immunization to nine-month-old Mexican children.

Wong-Chew RM, Islas-Romero R, García-García Mde L, Beeler JA, Audet S, Santos-Preciado JI, Gans H, Lew-Yasukawa L, Maldonado YA, Arvin AM, Valdespino-Gómez JL.

Vaccine. 2006 Jan 30;24(5):683-90. Epub 2005 Aug 24.

PMID:
16154241
5.

A simplified and standardized neutralization enzyme immunoassay for the quantification of measles neutralizing antibody.

Lee MS, Cohen B, Hand J, Nokes DJ.

J Virol Methods. 1999 Mar;78(1-2):209-17.

PMID:
10204711
6.

Persistence of vaccine-induced antibody to measles 26-33 years after vaccination.

Dine MS, Hutchins SS, Thomas A, Williams I, Bellini WJ, Redd SC.

J Infect Dis. 2004 May 1;189 Suppl 1:S123-30.

7.

Comparison of commercial enzyme immunoassay kits with plaque reduction neutralization test for detection of measles virus antibody.

Ratnam S, Gadag V, West R, Burris J, Oates E, Stead F, Bouilianne N.

J Clin Microbiol. 1995 Apr;33(4):811-5.

8.

Measurement of measles virus-specific neutralizing antibodies: evaluation of the syncytium inhibition assay in comparison with the plaque reduction neutralization test.

Ward BJ, Aouchiche S, Martel N, Bertley FM, Bautista-Lopez N, Serhir B, Ratnam S.

Diagn Microbiol Infect Dis. 1999 Mar;33(3):147-52.

PMID:
10092962
9.

Measles immunity testing: comparison of two measles IgG ELISAs with plaque reduction neutralisation assay.

Cohen BJ, Parry RP, Doblas D, Samuel D, Warrener L, Andrews N, Brown D.

J Virol Methods. 2006 Feb;131(2):209-12. Epub 2005 Sep 26.

PMID:
16188328
10.

Effect of Vitamin A supplementation on the immune response to measles vaccination.

Cherian T, Varkki S, Raghupathy P, Ratnam S, Chandra RK.

Vaccine. 2003 Jun 2;21(19-20):2418-20.

PMID:
12744873
11.

Development of a new neutralization test for measles virus.

Fujino M, Yoshida N, Kimura K, Zhou J, Motegi Y, Komase K, Nakayama T.

J Virol Methods. 2007 Jun;142(1-2):15-20. Epub 2007 Feb 23.

PMID:
17320979
12.

Immunogenicity and safety of aerosolized measles vaccine: systematic review and meta-analysis.

Low N, Kraemer S, Schneider M, Restrepo AM.

Vaccine. 2008 Jan 17;26(3):383-98. Epub 2007 Nov 26. Review.

PMID:
18082295
13.

A clinical study to assess the safety and immunogenicity of attenuated measles vaccine administered intranasally to healthy adults.

Simon JK, Pasetti MF, Viret JF, Mischler R, Muñoz A, Lagos R, Levine MM, Campbell JD.

Hum Vaccin. 2007 Mar-Apr;3(2):54-8. Epub 2007 Mar 10.

14.

Accuracy and repeatability of a micro plaque reduction neutralization test for vaccinia antibodies.

Borges MB, Kato SE, Damaso CR, Moussatché N, da Silva Freire M, Lambert Passos SR, do Nascimento JP.

Biologicals. 2008 Mar;36(2):105-10. Epub 2007 Sep 24.

PMID:
17892944
15.

Development of a focus reduction neutralization test (FRNT) for detection of mumps virus neutralizing antibodies.

Vaidya SR, Brown DW, Jin L, Samuel D, Andrews N, Brown KE.

J Virol Methods. 2010 Jan;163(1):153-6. doi: 10.1016/j.jviromet.2009.09.006. Epub 2009 Sep 15.

PMID:
19761798
16.

Immune response to measles vaccine in Peruvian children.

Bautista-López NL, Vaisberg A, Kanashiro R, Hernández H, Ward BJ.

Bull World Health Organ. 2001;79(11):1038-46.

17.

Induction of cellular and humoral immunity after aerosol or subcutaneous administration of Edmonston-Zagreb measles vaccine as a primary dose to 12-month-old children.

Wong-Chew RM, Islas-Romero R, García-García Mde L, Beeler JA, Audet S, Santos-Preciado JI, Gans H, Lew-Yasukawa L, Maldonado YA, Arvin AM, Valdespino-Gómez JL.

J Infect Dis. 2004 Jan 15;189(2):254-7. Epub 2004 Jan 5.

18.

Laboratory methods for assessing vaccine potency retained in aerosol outputs from nebulizers: application to World Health Organization measles aerosol project.

Cohen BJ, Parry RP, Andrews N, Bennett AM, Dennis JH.

Vaccine. 2008 Jun 25;26(27-28):3534-9. doi: 10.1016/j.vaccine.2008.04.027. Epub 2008 May 2.

PMID:
18490082
19.

Development of a gelatin particle agglutination reagent for measles antibody assay.

Sato TA, Miyamura K, Sakae K, Kobune F, Inouye S, Fujino R, Yamazaki S.

Arch Virol. 1997;142(10):1971-7.

PMID:
9413506
20.

Aerosol and subcutaneous measles vaccine: measles antibody responses 6 years after re-vaccination.

Dilraj A, Sukhoo R, Cutts FT, Bennett JV.

Vaccine. 2007 May 22;25(21):4170-4. Epub 2007 Mar 20.

PMID:
17408818
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk